Browse studies

Find your next paid study

5 recruiting studies matching your filters

Open-label Randomized, Three-fold Cross-over, Single-center Interaction Study to Investigate the Influence of Multiple Doses of Acetylsalicylic Acid (ASA) (Aspirin) on the Pharmacodynamics of BAY 3389934 in Healthy Participants.

The study treatment BAY3389934 is under development for people with blood clotting problems that occur due to sepsis. Sepsis is a serious condition that happen…

Drug-drug Interaction

Estimated

~$500 – $11,250

Actual pay is set by the research site.

BayerNCT07652723

Phase 1

Open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671 Added to Stable Allopurinol Therapy in Gout Patients

This is a open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671 Added to Stable Allopurinol Therapy in Gout Patients. Pharmacokinetic (PK) interact…

Gout ChronicGoutDDI (Drug-Drug Interaction)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Atom Therapeutics Co., LtdNCT07367971

Phase 1

Effect of CYP2B6 Genotype and Efavirenz on the Disposition and Pharmacodynamic of Methadone and Tizanidine in Healthy Volunteers

The main goal of this clinical study is to test how CYP2B6 genetic variations and efavirenz (cornerstone in HIV-1 therapy) dictate the disposition (PK) of CYP2…

Drug-Drug Interaction

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Indiana UniversityNCT05789173

Phase 1

A Phase 1, Open-label Study to Evaluate the Safety and to Characterize the Pharmacokinetics of a Fixed-Dose Combination Formulation of Ceftibuten-Ledaborbactam Etzadroxil

This is a Phase 1, open-label, three-part, study in approximately 96 healthy adult participants between 18 and 55 years of age (both inclusive) (16 participant…

Healthy VolunteerPharmacokineticsSafety+2 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Basilea PharmaceuticaNCT06733675

Phase 1

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology or Other Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary…

Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.